MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NOTE 7 - TRADING SECURITIES

NOTE 7 - TRADING SECURITIES

9 Months Ended

Sep. 30, 2012

NOTE 7 - Trading Securities

Marketable equity securities			Cost				Market value				Unrealized Loss
		$	47,500			$	12,000			$	35,500

Fair market measurement at September 30, 2012 were computed using quoted prices in an active market for identified assets, (level 1). The shares were obtained as compensation for performing consulting services.

During the nine months ended September 30, 2012 the Company sold 100,000 shares of marketable equity securities for a loss of $6,523.

The unrealized loss for the nine months ended September 30, 2012 is $35,500 and is included in the Statement of Operations.

- Definition

Disclosure of accounting policy for investments in debt and equity securities that are classified as trading securities. This policy also may describe the entity's accounting treatment for transfers between investment categories and how the fair values of such securities are determined.

+ References + Details